2Kjedsen SE, Farsang C, Sleigh P et al. 1999 WHO/ISH hypertension guidlines - highlights and ESH update. Hypertens, 2001; 19 (12): 2285～2288.
3Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC7 report. JAMA, 2003; 289 (19): 2560～2572.
4Progress Collaborative Group. Randomised trial of a perindopril- based blood- pressure- lowering regimen a mong 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001; 358 (9287): 1033 ～1041.
5Poole- Wilson PA, Lubsen J, Kirwan BA et al. Effect of long- acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring teatment (ACTION tral): randomised controlled trial. Lancet,2004; 364 (9437): 849～857.
6Wachtell K, Lehto M, Gerdts E. Angiotensin Ⅱ receptor blockade reduces new - onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study,J Am Coll Cardiol, 2005; 45 (5): 712～719.
7Siragy HM. Major outcomes in high- risk hypertensive patients randomized to angiotensin - converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid - Lowering Treatment to Prevent.Heart Attack Trial (ALLHAT). Curr Hypertens Rep,2003; 5 (4): 293～294.
8Ananda AI, Irene MS, Neil HAW et al. Association of systolic blood pressure with macrovascular and microvascular complications of type2 diabetes (UKPDS36): prospective observationalstudy. Br MedJ, 2000; 321 (7258): 412～419.
9Sever PS, Dahlof B, Poulter NR. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower - than - average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT - LLA): a multicentre randomised controlled trial. Lancet, 2003;361 (9364): 1149～1158.
10European Society of Hypertension- European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003; 21 (6): 1011～1053.
